- The trend backdrop is active with a 5-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
SUDARSCHEM
NSI
Week ended 07 Aug 2026
Weekly Investor Report
Sudarshan Chemical Industries Limited · Basic Materials · Specialty Chemicals
Latest close
1,140 INR
11.9%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 25.5% above the Trend Line and sits at 47.1% of its 52-week range. The latest completed week returned 11.9%, after a 14.0% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 54/100.
Setup score
61
out of 100
Latest Close
1,140 INR
7 Aug 2026
1W Return
11.9%
latest completed week
4W Return
14.0%
short-term follow-through
12W Return
31.2%
quarterly tape
Trend Breadth
30.8%
16 of 52 weeks active
Volume Ratio
1.5x
vs 13-week average
- The share remains more than 20% below its 52-week high.
- Recent volatility is running well above the one-year baseline.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
11.9%
Latest completed week; four-week move 14.0%.
Indicator stack
34/91
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
54/100
26 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 25.5% above the Trend Line and sits at 47.1% of its 52-week range. The latest completed week returned 11.9%, after a 14.0% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.5x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.4512-week average 0.32
12-week confirmation
Trend active5/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership4/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.45Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 14.0% over four weeks, 31.2% over 12 weeks, and -21.7% over one year. The current trend has remained active for 5 consecutive weeks.
Performance by holding period
Active trend streak5 weeks
Active weeks in one year16
Trend breadth30.8%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.89Latest activity-pressure read.
Pressure change85.4%Four-week change in activity pressure.
Leadership11.83Latest relative-leadership reading.
RS change589.7%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 94%
Model confidence 88%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength69/100Blend of value, momentum, and quality. Underlying universe rank 32; rank 1 is best.
Value72/100Relative valuation strength. Underlying universe rank 29; rank 1 is best.
Quality72/100Profitability and accounting quality. Underlying universe rank 29; rank 1 is best.
Momentum15/100Medium-term price momentum. Underlying universe rank 86; rank 1 is best.
Growth62/100Revenue and earnings growth. Underlying universe rank 39; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework97/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 406.8x Price divided by trailing earnings.
- Price / sales
- 0.9x Market value relative to trailing revenue.
- EV / EBITDA
- 16.5x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 0.7% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 49.2% Gross profit retained from each unit of revenue.
- Operating margin
- 15.7% Operating profit retained from revenue.
- Free-cash-flow margin
- 0.8% Free cash flow generated from revenue.
- Return on invested capital
- 23.1% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 193.8% Latest one-year revenue growth.
- EPS growth
- -60.1% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- - Latest one-year free-cash-flow growth.
- Piotroski F-score
- 5/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 0.4% Cash dividends relative to market value.
- Buyback yield
- -0.0% Net share repurchases relative to market value.
- Shareholder yield
- 0.4% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 2.3x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment54/100
Weighted news tone is neutral across 26 relevant articles.
7 positive · 18 neutral · 1 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-28.9%Distance below the 52-week high.
13-week volatility7.2%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher13 of 2613 weeks finished lower.
Best week+16.6%Week of 22 May.
Worst week-8.3%Week of 15 May.
Latest week+11.9%Week of 7 Aug.
Shape of recent returns
Strong gains6
Modest gains7
Flat weeks0
Modest losses8
Sharp losses5
Recent vol7.2%13-week weekly-return volatility.
Base vol5.0%52-week weekly-return volatility.
Up/down split20/32Count of positive and negative weeks in the 52-week window.
Average skew4.6% / -3.5%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorIN Basic Materials
4-week rank7 / 100
Group average2.8%
Trend breadth52.0%
Trend52.0%active weekly trend signals
MD52.0%positive activity pressure
RS63.0%positive relative leadership
Four-week leaders
IndustryIN Specialty Chemicals
4-week rank20 / 100
Group average5.8%
Trend breadth77.0%
Trend77.0%active weekly trend signals
MD75.0%positive activity pressure
RS72.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape55/100
Trend, activity pressure, participation, and risk combine to a 55/100 tape read.
Indicator analysis54/100Latest 12-week confirmation: trend 5/12, activity pressure 12/12, relative leadership 4/12.
Activity pressure 0.45; No reversal markers Factors58/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 72; Small Cap Core rank 59 SVQF97/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 43.5 of 1576 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment54/100Weighted news tone is neutral across 26 relevant articles.
Eastman Chemical Company (EMN) Stock Price, News, Quote & History Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 1,140 INR | 11.9% | 907.8 INR | 909.6 INR | 1.89 | 11.83 | 1.7M | On |
| 31 Jul 2026 | 1,018 INR | -2.2% | 901.2 INR | 905.6 INR | 1.77 | 0.05 | 973.6K | On |
| 24 Jul 2026 | 1,041 INR | 0.3% | 899.3 INR | 902.4 INR | 1.58 | 4.21 | 698.7K | On |
| 17 Jul 2026 | 1,038 INR | 3.8% | 895.9 INR | 898.8 INR | 1.31 | 1.16 | 2.1M | On |
| 10 Jul 2026 | 999.2 INR | 9.8% | 893.7 INR | 895.2 INR | 1.02 | -2.42 | 2.3M | On |
| 3 Jul 2026 | 910.3 INR | 2.1% | 893.6 INR | 891.8 INR | 0.79 | -11.62 | 274.8K | Off |
| 26 Jun 2026 | 891.2 INR | -2.4% | 896.4 INR | 889.0 INR | 0.76 | -13.16 | 0 | Off |
| 19 Jun 2026 | 913.6 INR | 3.6% | 900.4 INR | 886.4 INR | 0.97 | -11.30 | 248.0K | Off |
| 12 Jun 2026 | 882.2 INR | -0.5% | 904.1 INR | 883.7 INR | 1.19 | -13.36 | 90.5K | Off |
| 5 Jun 2026 | 886.7 INR | -5.5% | 909.3 INR | 881.2 INR | 1.20 | -12.49 | 71.0K | Off |
| 29 May 2026 | 938.0 INR | -7.4% | 915.6 INR | 878.6 INR | 1.36 | -8.49 | 2.9M | Off |
| 22 May 2026 | 1,013 INR | 16.6% | 922.6 INR | 875.5 INR | 1.28 | -2.22 | 2.5M | Off |
| 15 May 2026 | 868.6 INR | -8.3% | 928.7 INR | 872.0 INR | 1.06 | -15.97 | 508.1K | Off |
| 8 May 2026 | 947.3 INR | 3.6% | 941.1 INR | 868.9 INR | 1.12 | -10.62 | 1.3M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.